FormulationInput,SNo,MedicineName,Status,CeilingPrice,Unit,MRP_Unit,CapturedAt,Formulation_Brand,CompanyName_Header,MRP_Unit_Header,MRP_AsOnDate,MRP_Header,Sub_SNo,Sub_BrandName,Sub_PackSize,Sub_MRP,Sub_MRP_Unit,Sub_CompanyName
DAPAGLIFLOZIN & METFORMIN & SITAGLIPTIN,,JABRYUS 100 MG TABLET 7,JABRYUS 100 MG TABLET 7,Non-Scheduled,Not Applicable,TABLET,2026-01-23T13:50:37,Abrocitinib TABLET 100 MG / JABRYUS,GLENMARK PHARMACEUTICALS LTD.,7366.07,Dec-2025,51562.50/7 TABLET,,,,,,
DAPAGLIFLOZIN & METFORMIN & SITAGLIPTIN,,JABRYUS 200 MG TABLET 7,JABRYUS 200 MG TABLET 7,Non-Scheduled,Not Applicable,TABLET,2026-01-23T13:50:39,Abrocitinib TABLET 200 MG / JABRYUS,GLENMARK PHARMACEUTICALS LTD.,10054.69,Dec-2025,70382.81/7 TABLET,,,,,,
DAPAGLIFLOZIN & METFORMIN & SITAGLIPTIN,,JABRYUS 50 MG TABLET 7,JABRYUS 50 MG TABLET 7,Non-Scheduled,Not Applicable,TABLET,2026-01-23T13:50:41,Abrocitinib TABLET 50 MG / JABRYUS,GLENMARK PHARMACEUTICALS LTD.,1571.43,Dec-2025,11000.00/7 TABLET,,,,,,
